Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 Sep 23;67(1):27–32. doi: 10.1111/epi.18651

Beyond the spike: Functional (dissociative) seizures as a key to holistic attitudes in seizure disorders

Mahinda Yogarajah 1,2,, Barbara Dworetzky 3, Josemir W Sander 1,2, Angel Aledo‐Serrano 4
PMCID: PMC12893246  PMID: 40985906

Abstract

Epileptologists can improve outcomes through follow‐up and coordination of care for patients with functional seizures. Epileptic and functional seizures share some mechanistic overlap involving interoceptive, emotional, and stress dysregulation, and disorders of agency and perception. Similar psychiatric and neurological comorbidities occur at comparable rates in both functional and epileptic seizure populations. A holistic, biopsychosocial approach benefits all seizure patients and reflects modern models of epilepsy care.

Keywords: epilepsy, epileptic seizures, functional/dissociative seizures

1. INTRODUCTION

People with functional or dissociative seizures (FDS) are at least as common as those with multiple sclerosis, 1 , 2 , 3 with an incidence ≈3/100 000/year and prevalence of 24–109/100 000. However, these values likely underestimate the true frequency, given that most studies restrict case ascertainment to video‐electroencephalographic (EEG) telemetry‐confirmed diagnoses, which is the minority in routine practice. In a typical seizure disorder clinic, more than one fifth of people attending for the first time have FDS and not epileptic seizures (ES). 4 Beyond diagnostic considerations, however, epilepsy specialists and funding agencies are often reluctant to engage clinically and academically with this disorder. FDS are typically dismissed as outside the remit of epileptologists. Arguments against involvement include the absence of hypersynchronized neuronal discharges in FDS and the perceived greater psychiatric complexity of these individuals. 5 The result is a significant gap in care and research funding. 6 This neglect has clinical and economic consequences, as people with FDS incur health care costs, 7 morbidity levels,8 and premature mortality rates 9 similar to those associated with ES.

We highlight the inherent contradictions in these arguments (Table 1). We advocate that seizure specialists should take a more central clinical and academic role regarding FDS, ideally within a multidisciplinary framework.

TABLE 1.

Rationale for greater epileptologist engagement with functional seizures.

Domain Rationale
Prevalence & burden Functional seizures are common in seizure clinics and carry similar morbidity, mortality, and health care costs as epilepsy
Clinical responsibility Neurologists diagnose FDS and are well placed to optimize ASM use, assess new symptoms, and coordinate care
Treatment impact Even brief neurologist‐led interventions (e.g., motivational interviewing, outpatient follow‐up) can reduce seizure frequency and improve outcomes
Comorbidity overlap High rates of psychiatric and neurological comorbidities (e.g., PTSD, ASD, TBI) are present in both FDS and epilepsy
Mechanistic convergence Shared network dysfunction, stress biology, autonomic and interoceptive pathways, and abnormalities of perception link FDS and epilepsy
Therapeutic cross‐benefit Neurobehavioral therapies developed for FDS may benefit epilepsy patients, suggesting overlapping treatment targets
Mixed diagnosis Many patients have both epileptic and functional seizures, requiring integrated and nuanced management
Changing models of epilepsy Network‐based and biopsychosocial models of epilepsy align with FDS frameworks, challenging rigid spike‐based definitions
Health system precedent Other specialties (e.g., gastroenterology, movement disorders) take active roles in managing functional conditions

2. A ROLE BEYOND MAKING A DIAGNOSIS

Because people with FDS present to seizure disorder clinics, specialists in these settings have an established diagnostic role. However, the idea that this is their only role, while management and research are left to others, is at odds with other functional disorders. Although specialized epilepsy‐led multidisciplinary services for FDS are limited, there exist gastroenterology‐led and coordinated multidisciplinary services for irritable bowel syndrome. 10 Even within neurology, in an international survey of 864 movement disorder specialists, 60% considered that their primary responsibility was not only to provide a diagnosis, but also to coordinate interdisciplinary management of functional movement disorders. 11 This is in contrast to the opinions expressed by epileptologists in a comparable study where only a minority held similar views. 12

In individuals with FDS alone, seizure specialists play an essential research and clinical role. Even the minimum of care, that is, the provision of follow‐up appointments, has indirect benefits. Seizure specialists are best placed to wean inappropriately prescribed antiseizure medications (ASMs), assess new seizure manifestations, and manage common comorbid neurological conditions such as migraine. Optimizing the management of these conditions typically improves the frequency of the FDS. 13 More implicit benefits arise from the finding that people with FDS view their seizures as biological and psychological. 14 Continuing neurology input leads to increased engagement with psychological/psychiatric services, resulting in improved outcomes. In the CODES (Cognitive Behavioral Therapy Versus Standardized Medical Care for Adults With Dissociative Non‐Epileptic Seizures) study, which is the largest study of cognitive behavioral therapy (CBT) in FDS, there was no difference in seizure frequency when comparing standardized medical care alone and standardized medical care with CBT. 15 This may partly have been because standardized medical care consisted of structured neurology input, alongside psychiatric follow‐up. 16 A smaller Australian study showed significant health economic savings in individuals with FDS when there was continuing neurology follow‐up. 17

With appropriate resources and training, interested seizure disorder specialists could provide more direct care for these individuals. This could range from helping to coordinate multidisciplinary care among psychiatrists and psychologists already embedded within a seizure disorder service 18 to delivering brief but impactful interventions. A randomized controlled trial showed that a neurologist with minimal training and using a single 30‐min session of motivational interviewing doubled psychotherapy uptake. Moreover their interviewing also led to a measurable reduction in seizure frequency, even among those who never accessed therapy. 19

Lastly, seizure disorder specialists should also engage with this condition beyond diagnosis, because of the frequent co‐occurrence of both epileptic and functional seizures. 20 The challenge is not only to distinguish between the two seizure types, but to manage them holistically, especially given that one is primarily treated pharmacologically with ASMs, and the other requires a multidisciplinary, nonpharmacological approach.

Seizure specialists have the expertise to make a diagnosis of FDS, and general psychiatrists are frequently either skeptical regarding the diagnosis or lack confidence and experience in managing it. 5 , 21 It is therefore essential that seizure specialists step forward to help coordinate the management and deliver care to these individuals.

3. BIOLOGY BEYOND HYPERSYNCHRONIZATION

Despite the disinterest in FDS, epilepsy specialists readily engage clinically and academically with other types of seizures in individuals without epilepsy, such as provoked seizures caused by other conditions. The argument offered is that there are common seizure mechanisms, such as neuronal hypersynchronization, so that the study of provoked seizures can help to understand how external and/or internal factors modulate epileptic seizures. However, FDS also provide a window for understanding how other, more distal mechanisms may be relevant in epileptic seizures. Research into the neurobiology of FDS has shown that stress biology, autonomic and interoceptive dysfunction, and emotional dysregulation can modulate FDS. 22 These biological systems are also relevant to people with epilepsy, where it is accepted that autonomic dysfunction has a role in sudden unexpected death in epilepsy. 23 Psychological stress can exacerbate ES, and emotional dysregulation plays a role in psychiatric comorbidity and quality of life. 24 The overlap is reflected in contemporary mechanistic models of functional neurological disorders and FDS. These disorders can be conceptualized within the framework of abnormal functioning of relevant brain networks, such as the default mode, salience and attentional networks, alongside psychosocial factors. 25 This network‐based perspective aligns with recent shifts in epilepsy research, where the disorder, and especially interictal comorbidity, are now increasingly viewed as a disruption across interconnected brain systems. 26 , 27 In acknowledging the possibility of mechanistic overlap, it follows that treatment for FDS may offer some benefit to those with epileptic seizures. A prospective trial of neurobehavioral therapy demonstrated that a structured, multimodal psychotherapy originally developed for FDS could also significantly reduce seizure frequency in people with epilepsy during the active treatment phase. 28 The epilepsy cohort experienced a 34% reduction in monthly seizure frequency during neurobehavioral therapy, with seizure freedom achieved in 74% of participants by the end of treatment. However, these gains were not sustained at the 1‐year follow‐up. These improvements occurred without changes to ASMs. They may be due to shared neurobiological mechanisms between epilepsy and FDS, involving arousal, stress, and emotional regulation, all of which are targeted in neurobehavioral therapy. Neurobehavioral therapy integrates cognitive, psychodynamic, mindfulness, and self‐regulation strategies, which may support improved seizure control through greater self‐awareness, reduction of trigger sensitivity, and enhanced stress resilience. The observed improvements suggest that such therapies warrant further exploration in epilepsy care as adjunctive treatments.

Other mechanistic overlaps have emerged through the use of long‐term subcutaneous EEG recordings in people with epilepsy. 29 Individuals report events that are not epileptic seizures and miss events that are epileptic seizures. The most recent study of long‐term subcutaneous EEG recording in 31 individuals with epilepsy over 6 months noted that self‐reported nonepileptic events (n = 84) and unreported electrographic seizures (n = 14) both outnumbered self‐reported electrographic seizures. 30 This raises a critical question: where do ES end and FDS begin in these individuals, most of whom would not be categorized as having "typical functional seizures." In ES, there are inherent and underexplored disturbances in perception, agency, and consciousness, concepts that fundamentally define functional seizures. 31

Taking more of an interest in the biological underpinnings of FDS may help us understand why seizure reporting is often inaccurate in ES, and how higher order factors such as stress, attention, and emotion affect epileptic seizures. Dismissing FDS because they lack EEG spikes risks ignoring mechanisms relevant to both conditions (Figure 1).

FIGURE 1.

FIGURE 1

The mechanistic overlap between epileptic and functional/dissociative seizures.

4. BEYOND ASMs: NEED FOR A BIOPSYCHOSOCIAL APPROACH

Some argue that FDS are too complex because of significant psychosocial comorbidities. However, one third of people with FDS have no significant psychiatric comorbidity. 16 In the remainder, although meta‐analyses confirm that psychiatric comorbidity is approximately 1.3 times more common in FDS than ES, 32 there are high levels of psychiatric comorbidity in drug‐resistant epilepsy, with rates of >50% in large studies. 33 Psychiatric comorbidities traditionally associated with FDS such as posttraumatic stress disorder and somatic symptom disorder are now recognized to be present at elevated rates (18% 34 and 24%,35 respectively) in people with ES. There are complex interactions between comorbidities, including depression, anxiety, and somatic symptom disorder, that determine the quality of life in ES individuals. 36 , 37 Similarly, autism spectrum disorder 38 and traumatic brain injury,39 which have long been associated with epilepsy, are now recognized in nearly 20% 40 and 70%,41 respectively, of individuals with functional seizures. Comorbidities in both disorders have roots in a complex interplay of biological, psychiatric/psychological, and social processes. Complexity is not unique to FDS. The biopsychosocial model, long recognized as integral to the management of FDS, should be extended to those with ES, where it may likewise improve outcomes. 42

5. THE WAY FORWARD

If one defines epilepsy so narrowly that only spike‐driven events fall within its remit, one must accept that this definition also fails many of those with epilepsy too, particularly those with unmeasurable, subjective, or comorbid phenomena that nonetheless define their lived experience. If this is acknowledged, then it follows that epilepsy specialists have a central role in treating what individuals experience as seizures, regardless of mechanism. FDS, especially when comorbid with epilepsy, falls squarely within the remit of an epileptologist.

Functional seizures offer valuable insights and relevant information to enhance our understanding of ES and their management. Integrating FDS into epilepsy practice and research is feasible and essential to the holistic evolution of comprehensive care and research. We urge funding agencies to include functional seizures in research agendas, and health care providers to foster a more inclusive environment that addresses the multifaceted nature of seizure disorders. Interdisciplinary training, research grants, and integrated care models are avenues to enhanced understanding, improved individual and quality of life outcomes, and lower health care costs regardless of seizure type.

AUTHOR CONTRIBUTIONS

All authors contributed to all aspects of the article.

FUNDING INFORMATION

M.Y. is funded by an MRC CARP award (MR/V037676/1).

Abbreviations: ASD, autism spectrum disorder; ASM, antiseizure medication; FDS, functional or dissociative seizures; PTSD, posttraumatic stress disorder; TBI, traumatic brain injury.

CONFLICT OF INTEREST STATEMENT

M.Y. has served as a consultant providing specialist medicolegal advice regarding functional seizures. B.D. is president of the Functional Neurological Disorder Society. The other authors have no conflicts of interest to declare concerning this article. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

ACKNOWLEDGMENTS

The authors have nothing to report.

Yogarajah M, Dworetzky B, Sander JW, Aledo‐Serrano A. Beyond the spike: Functional (dissociative) seizures as a key to holistic attitudes in seizure disorders. Epilepsia. 2026;67:27–32. 10.1111/epi.18651

REFERENCES

  • 1. Villagrán A, Eldøen G, Duncan R, Aaberg KM, Hofoss D, Lossius MI. Incidence and prevalence of psychogenic nonepileptic seizures in a Norwegian county: a 10‐year population‐based study. Epilepsia. 2021;62:1528–1535. [DOI] [PubMed] [Google Scholar]
  • 2. Asadi‐Pooya AA. Incidence and prevalence of psychogenic nonepileptic seizures (functional seizures): a systematic review and an analytical study. Int J Neurosci. 2023;133:598–603. [DOI] [PubMed] [Google Scholar]
  • 3. GBD 2017 US Neurological Disorders Collaborators , Feigin VL, Vos T, Alahdab F, Amit AML, Bärnighausen TW, et al. Burden of neurological disorders across the US from 1990‐2017: a global burden of disease study. JAMA Neurol. 2021;78:165–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lee SH, Gillespie C, Bandyopadhyay S, Nazari A, Ooi SZY, Park JJ, et al. National audit of pathways in epileptic seizure referrals (NAPIER): a national, multicentre audit of first seizure clinics throughout the UK and Ireland. Seizure Eur J Epilepsy. 2023;111:165–171. [DOI] [PubMed] [Google Scholar]
  • 5. Rawlings GH, Reuber M. Health care practitioners' perceptions of psychogenic nonepileptic seizures: a systematic review of qualitative and quantitative studies. Epilepsia. 2018;59:1109–1123. [DOI] [PubMed] [Google Scholar]
  • 6. Stephen CD, Fung V, Perez DL, Espay AJ. Comparison of inpatient and emergency department costs to research funding for functional neurologic disorder: an economic analysis. Neurology. 2025;104:e213445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. O'Mahony B, Nielsen G, Baxendale S, Edwards MJ, Yogarajah M. Economic cost of functional neurologic disorders: a systematic review. Neurology. 2023;101:e202–e214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Jungilligens J, Michaelis R, Popkirov S. Misdiagnosis of prolonged psychogenic non‐epileptic seizures as status epilepticus: epidemiology and associated risks. J Neurol Neurosurg Psychiatry. 2021;92:1341–1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Nightscales R, McCartney L, Auvrez C, Tao G, Barnard S, Malpas CB, et al. Mortality in patients with psychogenic nonepileptic seizures. Neurology. 2020;95:e643–e652. [DOI] [PubMed] [Google Scholar]
  • 10. Basnayake C, Kamm MA, Stanley A, Wilson‐O'Brien A, Burrell K, Lees‐Trinca I, et al. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open‐label, single‐centre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5:890–899. [DOI] [PubMed] [Google Scholar]
  • 11. LaFaver K, Lang AE, Stone J, Morgante F, Edwards M, Lidstone S, et al. Opinions and clinical practices related to diagnosing and managing functional (psychogenic) movement disorders: changes in the last decade. Eur J Neurol. 2020;27:975–984. [DOI] [PubMed] [Google Scholar]
  • 12. Asadi‐Pooya AA, Brigo F, Trinka E, Lattanzi S, Adel Kishk N, Karakis I, et al. A global survey on the attitudes of neurologists and psychiatrists about functional/psychogenic/dissociative/nonepileptic‐seizures/attacks, in the search of its name. Epilepsy Behav. 2023;145:109292. [DOI] [PubMed] [Google Scholar]
  • 13. Duque L, Garza I, Cascino GD, Staab JP. Functional neurological seizures and migraine: a systematic review and case series. Epilepsy Behav. 2023;147:109437. [DOI] [PubMed] [Google Scholar]
  • 14. Whitehead K, Kandler R, Reuber M. Patients' and neurologists' perception of epilepsy and psychogenic nonepileptic seizures. Epilepsia. 2013;54:708–717. [DOI] [PubMed] [Google Scholar]
  • 15. Goldstein LH, Robinson EJ, Mellers JDC, Stone J, Carson A, Reuber M, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020;7:491–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Goldstein LH, Stone J, Reuber M, Landau S, Robinson EJ, Carson A, et al. Reflections on the CODES trial for adults with dissociative seizures: what we found and considerations for future studies. BMJ Neurol Open. 2024;6:e000659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Lagrand TJ, Jones M, Bernard A, Lehn AC. Health care utilization in functional neurologic disorders: impact of explaining the diagnosis of functional seizures on health care costs. Neurol Clin Pract. 2023;13:e200111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Libbon R, Gadbaw J, Watson M, Rothberg B, Sillau S, Heru A, et al. The feasibility of a multidisciplinary group therapy clinic for the treatment of nonepileptic seizures. Epilepsy Behav. 2019;98:117–123. [DOI] [PubMed] [Google Scholar]
  • 19. Tolchin B, Baslet G, Suzuki J, Martino S, Blumenfeld H, Hirsch LJ, et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia. 2019;60:986–995. [DOI] [PubMed] [Google Scholar]
  • 20. Kutlubaev MA, Xu Y, Hackett ML, Stone J. Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: systematic review and meta‐analysis of frequency, correlates, and outcomes. Epilepsy Behav. 2018;89:70–78. [DOI] [PubMed] [Google Scholar]
  • 21. Harden CL, Burgut FT, Kanner AM. The diagnostic significance of video‐EEG monitoring findings on pseudoseizure patients differs between neurologists and psychiatrists. Epilepsia. 2003;44:453–456. [DOI] [PubMed] [Google Scholar]
  • 22. Elkommos S, Martin‐Lopez D, Koreki A, Jolliffe C, Kandasamy R, Mula M, et al. Changes in the heartbeat‐evoked potential are associated with functional seizures. J Neurol Neurosurg Psychiatry. 2023;94:769–775. [DOI] [PubMed] [Google Scholar]
  • 23. Thijs RD, Ryvlin P, Surges R. Autonomic manifestations of epilepsy: emerging pathways to sudden death? Nat Rev Neurol. 2021;17:774–788. [DOI] [PubMed] [Google Scholar]
  • 24. Michaelis R, Schöller H, Popkirov S, Edelhäuser F, Kolenik T, Trinka E, et al. Psychological precursors of epileptic seizures. Epilepsia. 2024;65:e35–e40. 10.1111/epi.17865 [DOI] [PubMed] [Google Scholar]
  • 25. Drane DL, Fani N, Hallett M, Khalsa SS, Perez DL, Roberts NA. A framework for understanding the pathophysiology of functional neurological disorder. CNS Spectr. 2020:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Asadi‐Pooya AA, Brigo F, Tolchin B, Valente KD. Functional seizures are not less important than epilepsy. Epilepsy & Behavior Reports. 2021;16:100495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Slinger G, Otte WM, Braun KPJ, Van Diessen E. An updated systematic review and meta‐analysis of brain network organization in focal epilepsy: looking back and forth. Neurosci Biobehav Rev. 2022;132:211–223. [DOI] [PubMed] [Google Scholar]
  • 28. Van Patten R, Blum A, Correia S, et al. One‐year follow‐up of neurobehavioral therapy in functional seizures or epilepsy with traumatic brain injury: a nonrandomized controlled trial. Epilepsia. 2024;65:3545–3560. [DOI] [PubMed] [Google Scholar]
  • 29. Cook MJ, O'Brien TJ, Berkovic SF, Murphy M, Morokoff A, Fabinyi G, et al. Prediction of seizure likelihood with a long‐term, implanted seizure advisory system in patients with drug‐resistant epilepsy: a first‐in‐man study. Lancet Neurol. 2013;12:563–571. [DOI] [PubMed] [Google Scholar]
  • 30. Halliday AJ, Gillinder L, Lai A, Seneviratne U, Fontenot H, Cameron T, et al. The UMPIRE study: a first‐in‐human multicenter trial of bilateral subscalp monitoring for epileptic seizure detection. Epilepsia. 2025. 10.1111/epi.18458. Online ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75:1132–1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Diprose W, Sundram F, Menkes DB. Psychiatric comorbidity in psychogenic nonepileptic seizures compared with epilepsy. Epilepsy Behav. 2016;56:123–130. [DOI] [PubMed] [Google Scholar]
  • 33. Jansen C, Francomme L, Vignal J‐P, Jacquot C, Schwan R, Tyvaert L, et al. Interictal psychiatric comorbidities of drug‐resistant focal epilepsy: prevalence and influence of the localization of the epilepsy. Epilepsy Behav. 2019;94:288–296. [DOI] [PubMed] [Google Scholar]
  • 34. Pepi C, Mercier M, Salimbene L, Galati C, Specchio N, De Palma L. Post‐traumatic stress‐disorder in epilepsy: meta‐analysis of current evidence. Epilepsy Behav. 2024;157:109833. [DOI] [PubMed] [Google Scholar]
  • 35. Shen S, Dong Z, Sander JW, Zhou D, Li J. Somatic symptoms and related disorders in a large cohort of people with epilepsy: a cohort study. Epilepsia. 2023;64:320–334. [DOI] [PubMed] [Google Scholar]
  • 36. Shen S, Dong Z, Zhang Q, Xiao J, Zhou D, Li J. The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy. Ther Adv Neurol Disord. 2022;15:17562864221138147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Ma X, Shen S, Xu J, Yang R, Li J, Zhou D. Mediating effects of anxiety and depression on the relationship between somatic symptom disorder and quality of life among adults with epilepsy. Epilepsy Behav. 2025;169:110432. [DOI] [PubMed] [Google Scholar]
  • 38. Liu X, Sun X, Sun C, Zou M, Chen Y, Huang J, et al. Prevalence of epilepsy in autism spectrum disorders: a systematic review and meta‐analysis. Autism. 2022;26:33–50. [DOI] [PubMed] [Google Scholar]
  • 39. Fordington S, Manford M. A review of seizures and epilepsy following traumatic brain injury. J Neurol. 2020;267:3105–3111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. McWilliams A, Reilly C, Gupta J, Hadji‐Michael M, Srinivasan R, Heyman I. Autism spectrum disorder in children and young people with non‐epileptic seizures. Seizure. 2019;73:51–55. [DOI] [PubMed] [Google Scholar]
  • 41. Hickman LB, Patel AB, Dubey I, et al. Self‐reported severity and causes of traumatic brain injury in patients with epileptic or functional seizures. Neur Clin Pract. 2022;12:e189–e198. Available from: https://www.neurology.org/doi/10.1212/CPJ.0000000000200098. Accessed June 24, 2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Elliott JO, Richardson VE. The biopsychosocial model and quality of life in persons with active epilepsy. Epilepsy Behav. 2014;41:55–65. [DOI] [PubMed] [Google Scholar]

Articles from Epilepsia are provided here courtesy of Wiley

RESOURCES